Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

hVIVO reports favorable initial data from phase IIa study of PrEP-001 in influenza

April 25, 2016

GlaxoSmithKline and New York University describe antiprotozoal agents

April 25, 2016

FVM-04 neutralizes EBOV and SUDV in animal models

April 25, 2016

BL-84, a genetically optimized banana lectin for influenza

April 25, 2016

Achaogen awarded contract option by NIAID to support LpxC inhibitor research

April 22, 2016

NITD-008 and galidesivir improve survival and reduce viremia in AG129 mouse model of ZIKV infection

April 22, 2016

Lead Discovery Siena discloses guanidine derivatives

April 22, 2016

US Phytotherapy demonstrates dengue virus inhibition in preliminary cell culture studies

April 22, 2016

Genticel reports additional 12-month data from phase II trial of GTL-001

April 21, 2016

Eiger licenses PEGylated interferon lambda-1a rights from Bristol-Myers Squibb

April 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.